DE60306379T2 - Fluorsiloxanmatrixgesteuertes Arzneistoffdiffusionsabgabesystem - Google Patents

Fluorsiloxanmatrixgesteuertes Arzneistoffdiffusionsabgabesystem Download PDF

Info

Publication number
DE60306379T2
DE60306379T2 DE60306379T DE60306379T DE60306379T2 DE 60306379 T2 DE60306379 T2 DE 60306379T2 DE 60306379 T DE60306379 T DE 60306379T DE 60306379 T DE60306379 T DE 60306379T DE 60306379 T2 DE60306379 T2 DE 60306379T2
Authority
DE
Germany
Prior art keywords
methacrylate
agents
delivery system
matrix
drug diffusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60306379T
Other languages
German (de)
English (en)
Other versions
DE60306379D1 (de
Inventor
C. Joseph Fairport SALAMONE
F. Jay Canadaigua KUNZLER
M. Daniel Rochester AMMON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Application granted granted Critical
Publication of DE60306379D1 publication Critical patent/DE60306379D1/de
Publication of DE60306379T2 publication Critical patent/DE60306379T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
    • C08G77/24—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen halogen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04—Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/14—Polysiloxanes containing silicon bound to oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/20—Polysiloxanes containing silicon bound to unsaturated aliphatic groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42—Block-or graft-polymers containing polysiloxane sequences
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/70—Siloxanes defined by use of the MDTQ nomenclature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60306379T 2002-06-19 2003-06-16 Fluorsiloxanmatrixgesteuertes Arzneistoffdiffusionsabgabesystem Expired - Fee Related DE60306379T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/175,716 US20040043067A1 (en) 2002-06-19 2002-06-19 Fluorosiloxane matrix controlled diffusion drug delivery systems
US175716 2002-06-19
PCT/US2003/019026 WO2004000288A1 (en) 2002-06-19 2003-06-16 Fluorosiloxane matrix controlled diffusion drug delivery system

Publications (2)

Publication Number Publication Date
DE60306379D1 DE60306379D1 (de) 2006-08-03
DE60306379T2 true DE60306379T2 (de) 2007-06-14

Family

ID=29999052

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60306379T Expired - Fee Related DE60306379T2 (de) 2002-06-19 2003-06-16 Fluorsiloxanmatrixgesteuertes Arzneistoffdiffusionsabgabesystem

Country Status (17)

Country Link
US (1) US20040043067A1 (https=)
EP (1) EP1515705B1 (https=)
JP (1) JP2005530842A (https=)
CN (1) CN1662227A (https=)
AU (1) AU2003238247A1 (https=)
BR (1) BR0311963A (https=)
CA (1) CA2489987A1 (https=)
CZ (1) CZ200537A3 (https=)
DE (1) DE60306379T2 (https=)
ES (1) ES2261947T3 (https=)
MX (1) MXPA04012897A (https=)
PL (1) PL375000A1 (https=)
RU (1) RU2307667C2 (https=)
TW (1) TW200404569A (https=)
UA (1) UA80433C2 (https=)
WO (1) WO2004000288A1 (https=)
ZA (1) ZA200409979B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1765454T3 (en) 2004-07-02 2016-05-02 Mati Therapeutics Inc Device for submission of treatment medium to eye
US7544371B2 (en) * 2005-12-20 2009-06-09 Bausch + Lomb Incorporated Drug delivery systems
US20070148244A1 (en) * 2005-12-22 2007-06-28 Kunzler Jay F Drug delivery systems
US20070218104A1 (en) * 2006-03-15 2007-09-20 Bausch & Lomb Incorporation Rate controlled release of a pharmaceutical agent in a biodegradable device
US20070218103A1 (en) * 2006-03-15 2007-09-20 Bausch & Lomb Incorporated Rate controlled release of a pharmaceutical agent in a biodegradable device
EP2004172B1 (en) 2006-03-31 2019-03-13 Mati Therapeutics Inc. Drug delivery structures and compositions for nasolacrimal system
US7579021B2 (en) * 2006-09-27 2009-08-25 Bausch & Lomb Incorporated Drug delivery systems based on degradable cationic siloxanyl macromonomers
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
NZ583858A (en) 2007-09-07 2012-08-31 Quadra Logic Tech Inc Lacrimal implant detection with detection device
CA2701186C (en) * 2007-10-05 2017-09-19 Evonik Canada Inc. Oligofluorinated cross-linked polymers and uses thereof
AU2010206610A1 (en) * 2009-01-23 2011-08-11 Qlt Inc. Sustained released delivery of one or more agents
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
ES2727203T3 (es) 2011-08-29 2019-10-14 Mati Therapeutics Inc Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US4882377A (en) * 1988-09-21 1989-11-21 Dow Corning Corporation Low-viscosity pressure-adherent silicone elastomer compositions
US5321108A (en) * 1993-02-12 1994-06-14 Bausch & Lomb Incorporated Fluorosilicone hydrogels
US5463010A (en) * 1993-11-12 1995-10-31 Surface Engineering Technologies, Division Of Innerdyne, Inc. Hydrocyclosiloxane membrane prepared by plasma polymerization process
US6322815B1 (en) * 1994-07-22 2001-11-27 W. Mark Saltzman Multipart drug delivery system
DE69615393T2 (de) * 1995-12-07 2002-07-04 Bausch & Lomb Inc., Rochester Monomere zur reduzierung des modulus von siloxynhydrogele
BR9611859A (pt) * 1995-12-07 1999-05-04 Bausch & Lomb Composição de silicone polimérico com baixo teor de água lente de contato e método para produzir uma composição de silicone polimérico com baixo teor de água
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
ATE279461T1 (de) * 1997-04-03 2004-10-15 Guilford Pharm Inc Bioabbaubare terephthalat polyester-polyphosphat polymere, zusammensetzungen, gegenstände und verfahren für ihre herstellung und verwendung
US5908996A (en) * 1997-10-24 1999-06-01 Timewarp Technologies Ltd Device for controlling a musical performance
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
TWI284048B (en) * 2000-01-27 2007-07-21 Zentaris Ag Compressed microparticles for dry injection

Also Published As

Publication number Publication date
JP2005530842A (ja) 2005-10-13
RU2005100840A (ru) 2005-07-10
PL375000A1 (en) 2005-11-14
ZA200409979B (en) 2006-07-26
UA80433C2 (en) 2007-09-25
US20040043067A1 (en) 2004-03-04
MXPA04012897A (es) 2005-03-31
CZ200537A3 (cs) 2006-04-12
RU2307667C2 (ru) 2007-10-10
HK1070826A1 (en) 2005-06-30
ES2261947T3 (es) 2006-11-16
DE60306379D1 (de) 2006-08-03
EP1515705B1 (en) 2006-06-21
WO2004000288A1 (en) 2003-12-31
TW200404569A (en) 2004-04-01
BR0311963A (pt) 2005-03-29
EP1515705A1 (en) 2005-03-23
AU2003238247A1 (en) 2004-01-06
CA2489987A1 (en) 2003-12-31
CN1662227A (zh) 2005-08-31

Similar Documents

Publication Publication Date Title
DE60306379T2 (de) Fluorsiloxanmatrixgesteuertes Arzneistoffdiffusionsabgabesystem
Xue et al. PCL-based thermogelling polymer: molecular weight effects on its suitability as vitreous tamponade
DE3034505A1 (de) Kontaktlinsen aus einem copolymerisat aus polysiloxan, acrylsaeure und polyzyklischen estern von acrylsaeure oder methacrylsaeure
CN101437876A (zh) 生物聚硅氧烷
Wang et al. Applications and recent developments of hydrogels in ophthalmology
JP2008517878A (ja) ゲル粒子の形状保持凝集塊の形成の方法とその使用
JP2000516614A (ja) 製薬適用用組成物
WO2023221870A1 (zh) 聚氨酯类高分子聚合物及其制备方法，聚氨酯类高分子聚合物水凝胶、试剂盒及其应用
WO2023221873A1 (zh) 聚氨酯类高分子聚合物水凝胶及其制备方法和应用
DE3685869T2 (de) Formulierung mit verzoegerter wirkstoffabgabe, die ein hydrophobes polymersystem enthaelt.
US20180221490A1 (en) Sustained release of bioactive factors from zwitterionic hydrogels
WO2016033295A1 (en) Multilayer polymeric matrix based medical devices
KR20070122519A (ko) Ｐｅｇ－폴리아세탈 이블록 및 삼블록 공중합체 및 약학조성물
JP3898783B2 (ja) 生体内分解性ヒアルロン酸架橋ゲル組成物及び生体内分解性ヒアルロン酸架橋ゲル製剤
JP2003505584A (ja) 生物医学的組成物
EP3089766B1 (en) Ophthalmic viscosurgical device
US8642502B2 (en) Reversible gel-forming compositions for controlled delivery of bioactive substances
CA2737978C (en) Biodegradable polymer system
HK1070826B (en) Fluorosiloxane matrix controlled diffusion drug delivery system
US20070148244A1 (en) Drug delivery systems
US20250195427A1 (en) Anti-inflammatory drug-eluting compositions and methods
KR20050021025A (ko) 플루오로실록산 매트릭스 조절 확산 약물 전달계
JP2024506399A (ja) 一酸化窒素感応性ヒドロゲル
Cooper Dendrimer-based Therapeutic Delivery Vehicle for the Treatment of Ocular Diseases
WO2013056167A1 (en) Water-stable hydrogel and method using same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee